Advanced Search

Home > Journals > Minerva Biotecnologica > Past Issues > Minerva Biotecnologica 2005 September;17(3) > Minerva Biotecnologica 2005 September;17(3):107-17

ISSUES AND ARTICLES   MOST READ   eTOC

CURRENT ISSUEMINERVA BIOTECNOLOGICA

A Journal on Biotechnology and Molecular Biology


Indexed/Abstracted in: EMBASE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,246

 

Minerva Biotecnologica 2005 September;17(3):107-17

MEDICINAL PLANTS FOR BIOTECHNOLOGY AND BIOMEDICINE 

Oligosaccharides engineering from plants and algae applications in biotechnology and therapeutics

Delattre C., Michaud P., Courtois B., Courtois J.

Laboratory of Glucides-EPMV CNRS FRE 2779, IUT/GB, UPJV, Amiens, France

Since the last decade, newly observed functions of oligosaccharides are their ability to act as regulatory molecules on various organisms. The successful development of these compounds in future implies efficient processes for specific oligosaccharide production. For this reason, plant and algae constitute an original source of various oligosaccharidic structures. To exploit them, two strategies are available: synthesis (chemical or by enzymes) and polysaccharide cleavage (chemical, physical or biological). This review catalogues the possibilities of these methods, applied to plant and algae polysaccharide models, to generate bioactive oligosaccharides.

language: English


Full text temporarily not available online. Contact us  REPRINTS

top of page